View Detailed Profile
Imugene CEO Leslie Chong discusses FDA Fast Track Designation

Imugene CEO Leslie Chong discusses FDA Fast Track Designation

Imugene managing director

CEO Leslie Chong And COO Dr Bradley Glover Speak With JustStocks Video

CEO Leslie Chong And COO Dr Bradley Glover Speak With JustStocks Video

CEO Leslie Chong

Imugene’s Leslie Chong talks Azer-cel breakthrough

Imugene’s Leslie Chong talks Azer-cel breakthrough

Imugene

Imugene Ltd CEO & Managing Director Leslie Chong speaks with JustStocks

Imugene Ltd CEO & Managing Director Leslie Chong speaks with JustStocks

Imugene

Imugene CEO Leslie Chong presents at Wholesale Investor's Virtual Showcase July 2020

Imugene CEO Leslie Chong presents at Wholesale Investor's Virtual Showcase July 2020

Hear from

Imugene CEO Leslie Chong's presentation at the NWR Virtual Investor Conference August 2021.

Imugene CEO Leslie Chong's presentation at the NWR Virtual Investor Conference August 2021.

Watch

Imugene CEO Leslie Chong speaks about the company's positive new data at the ESMO Asia Congress 2022

Imugene CEO Leslie Chong speaks about the company's positive new data at the ESMO Asia Congress 2022

Learn more about this week's key ASX announcement and also upcoming conferences / investor presentations such as JP ...

Leslie Chong on Imugene’s 83% Response Rates & Path to FDA Approval | Fear & Greed

Leslie Chong on Imugene’s 83% Response Rates & Path to FDA Approval | Fear & Greed

Imugene CEO

Leslie Chong's first interview following our news Imugene secured two FDA IND approvals

Leslie Chong's first interview following our news Imugene secured two FDA IND approvals

Watch

Imugene Limited (ASX: IMU) Emergence 2024: Presentation by Leslie Chong, Managing Director and CEO

Imugene Limited (ASX: IMU) Emergence 2024: Presentation by Leslie Chong, Managing Director and CEO

Watch

Leslie Chong talks about Imugene's ABL partnership for VAXINIA

Leslie Chong talks about Imugene's ABL partnership for VAXINIA

Watch

CEO Leslie Chong interview with Proactive Investors on Phase 1 MAST Results

CEO Leslie Chong interview with Proactive Investors on Phase 1 MAST Results

Proactive Investors |

Imugene's CEO interviewed on ausbiz detailing a clinical trial deal with Merck Germany and Pfizer.

Imugene's CEO interviewed on ausbiz detailing a clinical trial deal with Merck Germany and Pfizer.

The clinical trail will evaluation